Status:
UNKNOWN
Use of Extracorporeal Treatment With the Cytosorb-Adsorber for the Reduction of SIRS in Heart Surgery Patients
Lead Sponsor:
University of Rostock
Conditions:
Multiple Organ Failure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Heart-surgery with the use of a heart-lung-machine can trigger the development of a full-blown SIRS (Systemic Inflammatory Response Syndrom) with multi organ failure and severe sepsis in the course of...
Detailed Description
All patients underlying heart surgery with the use of a heart-lung-machine and fullfilling of the inclusion-criteria should be sreened for the study. The study take place on two surgical intensive car...
Eligibility Criteria
Inclusion
- After heart surgery with heart-lung-machine
- 2 or more positive SIRS criterions within 6 hours postoperative
- need of \> 1,9 liter kristalloids within 6 hours postoperative
- centralvenous oxygen saturation \>75% within 6 hours postoperative
- need of vasopressors (≥0,06 µg/Kg/Min) within 6 hours postoperative
Exclusion
- Bleeding
- Thrombocyten \< 20.000 /µl, INR\>3,0
- HIV-Test positive
- Hepatitis C positive
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2022
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT02265419
Start Date
October 1 2014
End Date
March 1 2022
Last Update
April 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Intensive Care Units PIT 1+2, University hospital Rostock
Rostock, Germany, 18055